Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model
about
LipidHome: a database of theoretical lipids optimized for high throughput mass spectrometry lipidomicsNonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsDifferential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitisEnhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cellsDiffering endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat DietLipidomics: when apocrypha becomes canonical.A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.Lipidomic analysis of lipid droplets from murine hepatocytes reveals distinct signatures for nutritional stress.The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.The hepatic lipidome: a gateway to understanding the pathogenesis of alcohol-induced fatty liverMetabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progressionThe impact of genetic stress by ATGL deficiency on the lipidome of lipid droplets from murine hepatocytes.Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.Mass Spectrometry-Based Metabolomic and Lipidomic Analyses of the Effects of Dietary Platycodon grandiflorum on Liver and Serum of Obese Mice under a High-Fat Diet.Metabolomic Fingerprinting in the Comprehensive Study of Liver Changes Associated with Onion Supplementation in Hypercholesterolemic Wistar RatsRetinoids ameliorate insulin resistance in a leptin-dependent manner in mice.High-throughput and rapid quantification of lipids by nanoflow UPLC-ESI-MS/MS: application to the hepatic lipids of rabbits with nonalcoholic fatty liver disease.Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis.Sericin ameliorated dysmorphic mitochondria in high-cholesterol diet/streptozotocin rat by antioxidative property.Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).GPCR activation of Ras and PI3Kc in neutrophils depends on PLCb2/b3 and the RasGEF RasGRP4.Lipid Profiling of In Vitro Cell Models of Adipogenic Differentiation: Relationships With Mouse Adipose Tissues.Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice.Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH.A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis.Duodenal-jejunal bypass surgery induces hepatic lipidomic alterations associated with ameliorated hepatic steatosis in mice.Discovering a critical transition state from nonalcoholic hepatosteatosis to nonalcoholic steatohepatitis by lipidomics and dynamical network biomarkers.Analysis of the liver lipidome reveals insights into the protective effect of exercise on high-fat diet-induced hepatosteatosis in mice.Blood plasma lipidomic signature of epicardial fat in healthy obese women.Endogenous and xenobiotic metabolite profiling of liver extracts from SCID and chimeric humanized mice following repeated oral administration of troglitazone.Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort study.Diacylglycerol triggers Rim101 pathway-dependent necrosis in yeast: a model for lipotoxicity.Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice.ILDR2 has a negligible role in hepatic steatosis.Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome.Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment.
P2860
Q21133551-2DAE4CC4-B16F-4469-82E4-1333454C5606Q22299426-B3F5F9B8-BC57-4CD5-ADC3-3128E9CECD13Q28486701-E1E4B892-2F99-4519-BEA7-859B3944B13BQ33825109-63A29362-DF4F-4400-9C31-AE8CA891A5E9Q34166238-B1CA04A3-572E-4399-A122-5E41133FAD16Q35120968-0849F20C-7895-463B-A40E-DB76993780DEQ35630861-85DBD94C-8098-4AFC-9B0D-ED4B2FCAAF02Q35848129-55811854-4F53-4F3F-BEF6-C00F3FC2AB22Q35894884-E12CE4A5-E0CE-4155-8D32-811CD8E868DFQ35933771-124FB97F-B03C-4D56-B3DF-6B3F5A644007Q36213884-76880756-4CFF-4BFF-B960-FA197A93B2F3Q36329899-D57E55F0-CAA2-4DD3-965B-F5B86E2DA441Q36590606-54464115-4EC2-430B-AC79-78F644A425F6Q36947359-610567E9-63D8-4D03-8B5C-35EAEC19C2C8Q37002675-4DC5B0E7-2798-4E82-8465-A87421D8C860Q37405640-775C8CC2-A41C-43AF-AA90-69798AF9C8A9Q37628465-53AFF5AA-B9AE-4532-8DE1-239A3FE777BFQ37690687-F15D6D4A-CFAC-409F-885F-0E1E5E431743Q38325855-64091818-C0AD-421C-99E9-0FF64A88E3BFQ38414538-F2E2A836-7482-4110-A490-270C36FE019DQ38799232-06330AD3-33DA-4554-A1C1-4EF4426500CDQ38873508-BFC7BD9E-EF8E-419B-A38F-AEAA2F74FB8BQ39044073-CDC87E36-B218-4DC9-B989-108C5C3C56BEQ39326099-2DBA145D-FE0B-43BC-9AB3-5CD03B24B666Q39972407-AEF42E40-EF02-4BC8-BEA3-1EA966BAE29DQ41094296-BDEED251-E6DB-41C5-8E68-5FEF64D5B353Q42928898-F9DE4D62-B582-4E87-AD60-0F716B9925FDQ46364739-37D875AC-1121-4A24-8096-39462BF3BFC8Q46511203-93303B5B-3F44-462F-BBBC-00204BC3B53AQ46577273-9C1A9B51-94EE-4519-95BA-F76862E43C2FQ46767755-94ACB0BE-A9D2-4F11-AA32-B2C04598C0F4Q46813941-65663C6D-D45C-425E-971F-06FD19A65B66Q46957879-DFD0D655-47AB-44B8-991A-B8BBDE2F30B6Q47748477-2923DFFE-0987-4AA7-A574-58E02149BF23Q48138457-99352273-C8F4-450F-A953-668ADF25C5E1Q52699090-3F9CABCF-F023-4AD0-A718-6D8EC83A959CQ54977679-5954416F-3456-401D-84C9-61811377FF51Q55119909-FC8B3615-5513-448C-9726-84AA7DB45178Q55323878-E0972881-41E8-406B-A1E4-2C1C0F7B5689
P2860
Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Increased diacylglycerols char ...... ; comparison to a murine model
@ast
Increased diacylglycerols char ...... ; comparison to a murine model
@en
type
label
Increased diacylglycerols char ...... ; comparison to a murine model
@ast
Increased diacylglycerols char ...... ; comparison to a murine model
@en
prefLabel
Increased diacylglycerols char ...... ; comparison to a murine model
@ast
Increased diacylglycerols char ...... ; comparison to a murine model
@en
P2093
P2860
P1433
P1476
Increased diacylglycerols char ...... ; comparison to a murine model
@en
P2093
D Lee Gorden
David S Myers
H Alex Brown
J Kelly Wright
J Oliver McIntyre
Lynn M Matrisian
Michael N VanSaun
Pavlina T Ivanova
P2860
P304
P356
10.1371/JOURNAL.PONE.0022775
P407
P577
2011-08-09T00:00:00Z